The value of regulatory intelligence in pharma: Measuring and communicating the ROI

Measuring and communicating the ROI

The regulatory intelligence (RI) function continues to develop and increase in importance as companies operate globally. While the scope of RI varies by geography, resources and company size, it has become an essential component of maintaining awareness of and remaining compliant with the ever-evolving regulatory landscape.

However, RI often operates in the background of a company, with limited awareness of its value and contribution to the company’s success. The ability to determine the return on investment (ROI) of RI remains elusive for many companies, leaving senior leadership unclear on its value.

This report describes the importance of RI, key performance indicators (KPIs) that can be used to measure its value and opportunities to increase awareness of its contribution both internal and external to the company.